Mereo Biopharma Group Plc ADR (NASDAQ: MREO) is 71.00% higher on its value in year-to-date trading and has touched a low of $1.07 and a high of $4.50 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MREO stock was last observed hovering at around $3.76 in the last trading session, with the day’s gains setting it 0.19%.
Currently trading at $3.95, the stock is 0.71% and 3.71% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.31 million and changing 5.05% at the moment leaves the stock 26.51% off its SMA200. MREO registered 216.00% gain for a year compared to 6-month gain of 6.76%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -3.42% loss in the last 1 month and extending the period to 3 months gives it a 33.45%, and is 7.92% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.99% over the week and 6.65% over the month.
Mereo Biopharma Group Plc ADR (MREO) has around 33 employees, a market worth around $554.07M and $8.79M in sales. Profit margin for the company is -355.64%. Distance from 52-week low is 269.16% and -12.22% from its 52-week high. The company has generated returns on investments over the last 12 months (-39.47%).
The EPS is expected to grow by 15.00% this year
The shares outstanding are 140.27M, and float is at 140.27M with Short Float at 3.12%.
Mereo Biopharma Group Plc ADR (MREO) Insider Activity
The most recent transaction is an insider sale by Sermon Charles, the company’s General Counsel. SEC filings show that Sermon Charles sold 32,187 shares of the company’s common stock on Jun 26 ’24 at a price of $3.39 per share for a total of $0.11 million. Following the sale, the insider now owns 0.18 million shares.
Mereo Biopharma Group Plc ADR disclosed in a document filed with the SEC on Jun 25 ’24 that Sermon Charles (General Counsel) sold a total of 14,202 shares of the company’s common stock. The trade occurred on Jun 25 ’24 and was made at $3.69 per share for $52461.0. Following the transaction, the insider now directly holds 0.22 million shares of the MREO stock.
Still, SEC filings show that on Jun 26 ’24, Lewicki John A. (Chief Scientific Officer) disposed off 16,808 shares at an average price of $3.39 for $57033.0. The insider now directly holds 48,779 shares of Mereo Biopharma Group Plc ADR (MREO).
